A clinical trial in 2015 linked an undisclosed GLP-1 to significant improvements in OSA severity, while a 2016 clinical trial found that weight loss resulting from liraglutide was significantly associated with a reduction in the apnea-hypopnea index (AHI)
Lin CH, Chen CC, Chiang HL, Liou JM, Chang CM, Lu TP, et al
Recent evidence has increasingly linked ferroptosis to several diseases, such as liver ischemia/reperfusion injury, diabetes, acute kidney injury, and stroke, and in the context of the female reproductive system, our previous research has established a link between ferroptosis and PE 9,10
difficile infection, as well as foodborne bacterial infections such as Salmonella and E
Patients are embracing these options to: Break through stubborn plateaus after diet and exercise Reduce food noise, or constant preoccupation with eating Improve metabolic markers like blood sugar and cholesterol Lower the risks associated with being overweight or obese GLP-1 medications are now part of a broader movement toward medical weight loss management in medspas, giving clients science-based momentum for their health goals
